- Improving access to optimal medical diagnostics and therapy in non-metropolitan regions and low-resource settings
- Establishment of a supra-regional medical care amputation register
- Conducting studies on arteriogenesis
Within the last decades, the treatment of vascular diseases has improved enormously and many treatment approaches have been revolutionized. The current concept is described as an “endovascular-first approach”. First and foremost, non-surgical therapeutic measures of vascular occlusions, vascular constrictions or vessel aneurysms are used. Only if these methods do not show sufficient therapeutic success, combination interventions (so-called hybrid interventions) or vascular surgical measures are applied.
However, access to these optimized therapies for patients is highly unevenly distributed across the region, as:
- Therapy options are not known in all regions.
- The next specialist physician is often far from the patients home.
- The waiting time for an appointment can be weeks to months.
As a result, the benefits of modern vascular medicine are by no means accessible to all patients.
The EFVM is committed to reducing or even eliminating the total number of amputations in the long run, and to providing patients with access to modern endovascular therapies. In order to achieve this goal, it is first necessary to record the actual state of vascular amputations.
In cooperation with health insurance companies, clinics, doctors and patients – mainly in non-metropolitan regions and in low-resource settings – these data are collected. All performed amputations are then recorded in the Ampere Register as a superregional medical care register.
Through a subsequent scientific evaluation of the data, the Ampere Register will serve as a basis to sustainably improve vascular health in these mentioned regions. This way the patient can be offered new and personalized treatment strategies.